Windtree delisting occurred after Nasdaq notified the company it failed to meet Listing Rule 5550(a)(2)’s $1.00 minimum bid requirement; WINT shares plunged roughly 77% to $0.11 and Nasdaq will suspend trading, per Windtree’s SEC filing. Investors should review filings and monitor the company’s continued disclosures.
Nasdaq delisting notice: failure to meet $1.00 minimum bid under Listing Rule 5550(a)(2)
WINT share drop: fell ~77.2% to $0.11 and declined further in after-hours trading (Google Finance).
Corporate actions: announced BNB treasury, $60M purchase agreement, $500M equity line and $20M stock‑purchase pact.
Windtree delisting: WINT plunged after Nasdaq delisting notice. Read SEC filing details, BNB treasury impact, timelines and next steps for investors — stay informed now.
What is the Windtree delisting?
Windtree delisting refers to Nasdaq’s notification that Windtree Therapeutics (WINT) failed to maintain the minimum $1.00 bid price required by Nasdaq Listing Rule 5550(a)(2), triggering a delisting process and a scheduled trading suspension. The company disclosed the notice in an SEC filing and said it will continue periodic reporting.
‘,
‘
🚀 Advanced Trading Tools Await You!
Maximize your potential. Join now and start trading!
‘,
‘
📈 Professional Trading Platform
Leverage advanced tools and a wide range of coins to boost your investments. Sign up now!
‘
];
var adplace = document.getElementById(“ads-bitget”);
if (adplace) {
var sessperindex = parseInt(sessionStorage.getItem(“adsindexBitget”));
var adsindex = isNaN(sessperindex) ? Math.floor(Math.random() * adscodesBitget.length) : sessperindex;
adplace.innerHTML = adscodesBitget[adsindex];
sessperindex = adsindex === adscodesBitget.length – 1 ? 0 : adsindex + 1;
sessionStorage.setItem(“adsindexBitget”, sessperindex);
}
})();
WINT shares dropped approximately 77.2% to $0.11 on the delisting announcement and fell a further ~4.7% in after-hours trading, according to Google Finance. Nasdaq has set a suspension of WINT trading effective Thursday; the filing and market data outline the immediate impact for shareholders.
Windtree’s decline followed a brief run-up in mid‑July after announcing a BNB treasury strategy. The stock surged after the July 16 announcement but has since fallen more than 90% from its July 18 peak.
Windtree disclosed a BNB treasury strategy on July 16 that included a $60 million purchase agreement with Build and Build Corp and options for an additional $140 million. Market optimism briefly lifted WINT shares by 32.2% over two days, but the rally reversed sharply.
The company later announced a $500 million equity line of credit with an unnamed investor and a separate $20 million stock‑purchase pact with Build and Build Corp to acquire more BNB tokens. Windtree has not publicly detailed the amount of BNB it holds or its ongoing treasury allocation strategy.
‘
];
var adplace = document.getElementById(“ads-binance”);
if (adplace) {
var sessperindex = parseInt(sessionStorage.getItem(“adsindexBinance”));
var adsindex = isNaN(sessperindex) ? Math.floor(Math.random() * adscodesBinance.length) : sessperindex;
adplace.innerHTML = adscodesBinance[adsindex];
sessperindex = adsindex === adscodesBinance.length – 1 ? 0 : adsindex + 1;
sessionStorage.setItem(“adsindexBinance”, sessperindex);
}
})();
Source: https://en.coinotag.com/windtree-therapeutics-faces-potential-nasdaq-delisting-after-77-stock-drop-amid-bnb-treasury-strategy/